Lina receives WHO GMP certification
Confirming its capacity to manufacture high quality dry powder
capsules for inhalation in the treatment of Asthma, Sri Lanka’s first
ever centre for respiratory care formulation and manufacturing, Lina
Manufacturing, received the prestigious World Health Organization GMP
certification.
‘Good manufacturing practice’ or ‘GMP’ are practices and systems of
manufacturing, quality control, and quality systems covering the
manufacture and testing of pharmaceuticals or drugs including active
pharmaceutical ingredients.
“GMPs comprise 23 different aspects of production and testing that
can impact the quality of a product.
Many countries have introduced legislation to ensure pharmaceutical
and medical device companies follow GMP guidelines and procedures”
explained Rohan Wettasinghe.
“When Lina Manufacturing commenced production of Inhalation products
offering one of the most effective treatments for Asthma, a respiratory
disease with a high rate of occurrence locally, Sri Lanka had no
alternative but to import such treatments,” he elaborated.
In response to this vital need, a respected physician, Dr Anil
Goonatillaka commissioned and built Lina Manufacturing after more than
ten years of scrupulous research. Engaging a team of professionals,
renowned pharmacologists, production, quality assurance experts and
other specialists, to drive forward this project to manufacture
Respiratory Care Dry Powder for Inhalation (capsules) locally.
Lina Manufacturing requested and received technical assistance from
University of Moratuwa which designed the inhaler device required to
deliver medication to patients.
The only Sri Lankan manufacturer of the drug, Lina Manufacturing, is
a solely owned subsidiary of Akbar Pharmaceuticals Pvt Ltd. The company
which currently manufactures six products that include Steroids,
Bronchodilators, and many more, recently dispatched its first export
order promising greater demand and higher exchange income while earning
Sri Lanka pride prestige through this pioneering venture. |